INmune Bio, Inc. (INMB)
NASDAQ: INMB · IEX Real-Time Price · USD
11.57
+0.44 (3.95%)
At close: May 3, 2024, 4:00 PM
11.00
-0.57 (-4.93%)
After-hours: May 3, 2024, 5:57 PM EDT
INmune Bio Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$16.00
Upside
+38.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Initiates $16 | Buy | Initiates | $16 | +38.29% | Jun 1, 2023 |
| BTIG | BTIG | Strong Buy Maintains $31 → $14 | Strong Buy | Maintains | $31 → $14 | +21.00% | May 24, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy → Hold Downgrades $14 → $7 | Strong Buy → Hold | Downgrades | $14 → $7 | -39.50% | May 24, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $32 → $20 | Strong Buy | Maintains | $32 → $20 | +72.86% | Jan 24, 2022 |
| BTIG | BTIG | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 1, 2020 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jul 15, 2020 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | May 15, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 19, 2019 |